A detailed history of Mystic Asset Management, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Mystic Asset Management, Inc. holds 13,035 shares of NVO stock, worth $1.14 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
13,035
Previous 14,185 8.11%
Holding current value
$1.14 Million
Previous $2.02 Million 23.32%
% of portfolio
0.59%
Previous 0.83%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$119.07 - $145.42 $136,930 - $167,233
-1,150 Reduced 8.11%
13,035 $1.55 Million
Q2 2024

Aug 08, 2024

SELL
$122.71 - $146.91 $97,554 - $116,793
-795 Reduced 5.31%
14,185 $2.02 Million
Q1 2024

May 06, 2024

BUY
$102.11 - $135.92 $168,992 - $224,947
1,655 Added 12.42%
14,980 $1.92 Million
Q4 2023

Feb 12, 2024

SELL
$87.78 - $105.45 $64,079 - $76,978
-730 Reduced 5.19%
13,325 $1.38 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $619,756 - $1.36 Million
6,815 Added 94.13%
14,055 $1.28 Million
Q2 2023

Aug 11, 2023

SELL
$155.98 - $172.65 $80,329 - $88,914
-515 Reduced 6.64%
7,240 $1.17 Million
Q1 2023

Apr 21, 2023

SELL
$132.34 - $159.14 $19,851 - $23,870
-150 Reduced 1.9%
7,755 $1.23 Million
Q4 2022

Feb 03, 2023

SELL
$102.55 - $135.33 $12,818 - $16,916
-125 Reduced 1.56%
7,905 $1.07 Million
Q2 2022

Aug 12, 2022

SELL
$103.24 - $121.81 $27,874 - $32,888
-270 Reduced 3.25%
8,030 $894,000
Q1 2022

May 11, 2022

SELL
$93.1 - $112.54 $4,655 - $5,627
-50 Reduced 0.6%
8,300 $921,000
Q4 2021

Feb 23, 2022

BUY
$95.88 - $117.08 $800,598 - $977,618
8,350 New
8,350 $935,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Mystic Asset Management, Inc. Portfolio

Follow Mystic Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mystic Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mystic Asset Management, Inc. with notifications on news.